Building resilient, adaptable operations capable of evolving alongside the rapid transformation of the biologics industry is key for downstream processing.
Adam Goldstein
Advertisement
Adam Goldstein is senior director, R&D, Thermo Fisher Scientific.
Articles by Adam Goldstein
Advertisement
Latest Updated Articles
Advertisement
Advertisement